If you are wondering whether Recursion Pharmaceuticals is a bargain or a value trap at its current share price, this article will walk you through how its valuation stacks up using several common ...

Recursion Pharmaceuticals is helping pioneer the use of AI in drug discovery. The company's operating system tests ...

Detailed price information for Recursion Pharmaceuticals Inc Cl A (RXRX-Q) from The Globe and Mail including charting and trades.

Nvidia is not only a leading artificial intelligence chipmaker. It's also a tech investor whose holdings are closely watched ...

Similar to the trends during the last few weeks, Cathie Wood’s ARK exchange-traded funds continued to step up bets on AI and biotech names. Following last week's moves, the fund chopped holdings in ...

Recursion Pharmaceuticals Inc. stock reached a new 52-week low, closing at $3.53, just pennies away from its absolute 52-week bottom of $3.54. This milestone marks a significant downturn for the ...

See which small- and mid-cap stocks have the highest short interest (and squeeze risk) vs least shorted names, plus key ETFs to watch—read now.

In what’s shaping up to be one of the most dominant baby name dynasties in the province’s history, Olivia and Noah were once again the most popular baby names last year. This puts Olivia on a 13-year ...

With athletes from all around the world competing at the 2026 Winter Olympics, pronouncing their names can get a little tricky at times. Luckily, the official Olympics website has a handy way to help ...

Short sellers heavily ramped up their positions in small-cap biotech and health-tech by February month-end, creating a ...